Mechanistic insights of magnolol antimicrobial activity against
Mycoplasma synoviae
biofilm
cell membrane
growth
lipid
magnolol
metabolomics
pathogenicity
Journal
Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359
Informations de publication
Date de publication:
2023
2023
Historique:
received:
21
10
2023
accepted:
29
11
2023
medline:
28
12
2023
pubmed:
28
12
2023
entrez:
28
12
2023
Statut:
epublish
Résumé
The unreasonable use of antibiotics is one of the important causes of antimicrobial resistance (AMR) that poses a huge public health threat. Magnolol is a traditional Chinese medicine exhibiting antibacterial-, antifungal-, anti-inflammatory-, and antioxidant activities. However, it is unclear whether magnolol has an inhibitory effect on
Identifiants
pubmed: 38152121
doi: 10.3389/fcimb.2023.1325347
pmc: PMC10751911
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1325347Informations de copyright
Copyright © 2023 Qiao, Tengfei, Wenting, Qin, Yunqing, Xiaoyi, Huabin, Xinguo and Qingping.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.